Daria Jorg

Dr. Daria Jorg


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AKAdam Kabiesz
Adam Kabiesz
KDKarol Demel
Karol Demel
PGPiotr Gościniewicz
Piotr Gościniewicz
DJDaria Jorg
Daria Jorg
PZPatryk Zemła
Patryk Zemła
Background: This retrospective study compared the safety and efficacy of phacoemulsification performed with topical Cyclopentolate (Cykloftyal) versus a standard intracameral mydriatic and anesthetic combination (Mydrane) in patients undergoing RayOne EMV intraocular lens implantation. Materials and Methods: Medical records of 60 eyes (30 patients per group) were analyzed. Group A received topical Cyclopentolate and intracameral lidocaine, whereas Group B received intracameral Mydrane alone for mydriasis and anesthesia. Data on pupil diameter (at the start and end of surgery), procedure duration, and postoperative visual acuity at various distances were extracted and compared. Results: There was no statistically significant difference in surgical duration between Group A (7.05 min) and Group B (6.70 min; p=0.35), nor in postoperative visual acuity at any distance. However, the initial pupil diameter was significantly larger in the topical group (7.31±1.12 mm) than in the intracameral group (6.19±0.92 mm; p=0.04). Two months postoperatively, approximately 67% of patients in both groups reported spectacle independence for daily activities. Conclusions: Topical Cyclopentolate is a safe and effective alternative to intracameral mydriasis, providing significantly wider initial pupil dilation while maintaining comparable surgical efficiency. Additionally, the RayOne EMV lens demonstrated favorable outcomes in functional spectacle independence.